Prediction of contralateral progression in patients with bilateral nonhemorrhagic moyamoya disease following unilateral revascularization surgery

医学 烟雾病 外科 血运重建 内科学 心肌梗塞
作者
Chang Hwan Pang,Sang Hyo Lee,Taewon Choi,Hyoung Soo Byoun,Young-Deok Kim,Seung Pil Ban,Jae Seung Bang,O-Ki Kwon,Chang Wan Oh,Si Un Lee
出处
期刊:Journal of Neurosurgery [American Association of Neurological Surgeons]
卷期号:: 1-8 被引量:2
标识
DOI:10.3171/2024.5.jns2411
摘要

OBJECTIVE This study was designed to identify predictive factors associated with substantial contralateral progression in adult patients with bilateral nonhemorrhagic moyamoya disease (MMD) who undergo revascularization surgery (RS) on one hemisphere. METHODS The authors retrospectively analyzed 174 contralateral hemispheres of patients with bilateral nonhemorrhagic MMD (non-hMMD) who underwent RS on one side. The primary endpoint was defined as substantial contralateral progression requiring additional RS 6 months after the initial RS. The annual risk and predictive factors for contralateral progression were also analyzed. RESULTS Of 174 patients included in the study, 57 (32.8%) experienced contralateral progression over a mean follow-up of 45.3 ± 31.6 months (range 12–196 months). The annual risk for contralateral progression after initial unilateral RS was 7.7% per person-year. Multivariable analysis revealed that age (HR 0.967, 95% CI 0.944–0.992; p = 0.009) and a BMI ≥ 25 (HR 1.946, 95% CI 1.126–3.362; p = 0.017) were significant predictors of contralateral progression. Specifically, the annual risk of contralateral progression was 12.1% in the higher BMI (≥ 25) group and 4.0% in the lower BMI (< 25) group per person-year. CONCLUSIONS The study revealed a 7.7% per person-year rate of contralateral progression in patients with bilateral non-hMMD following unilateral RS. Younger age and a BMI ≥ 25 were identified as significant risk factors. For these patients, careful weight management and the use of antilipid agents may be crucial strategies for reducing the risk of contralateral progression after unilateral RS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
微笑完成签到,获得积分20
刚刚
李爱国应助山猪吃细糠采纳,获得10
刚刚
yaaabo发布了新的文献求助10
1秒前
柒_l完成签到,获得积分10
1秒前
joker完成签到,获得积分10
1秒前
1秒前
2秒前
科研蚂蚁完成签到,获得积分10
2秒前
duizhang发布了新的文献求助10
3秒前
共享精神应助houjibofa采纳,获得50
3秒前
tiger完成签到,获得积分10
4秒前
4秒前
4秒前
小二郎应助loraine采纳,获得10
4秒前
4秒前
4秒前
平淡的谷蓝完成签到,获得积分10
5秒前
香蕉觅云应助黑粉头头采纳,获得10
5秒前
5秒前
量子星尘发布了新的文献求助30
5秒前
小米完成签到,获得积分20
6秒前
6秒前
重要书文完成签到,获得积分10
6秒前
徐徐完成签到,获得积分10
6秒前
rice0601完成签到,获得积分10
7秒前
CodeCraft应助Jzhu96采纳,获得10
7秒前
7秒前
爱文字发布了新的文献求助20
7秒前
跳跳虎完成签到 ,获得积分10
8秒前
大个应助爱睡午觉采纳,获得10
8秒前
李健的粉丝团团长应助123采纳,获得10
8秒前
纳纳椰完成签到,获得积分10
8秒前
8秒前
娃娃菜妮发布了新的文献求助10
9秒前
hyue发布了新的文献求助30
9秒前
包容代芹发布了新的文献求助10
9秒前
顾矜应助888采纳,获得10
9秒前
seata完成签到,获得积分10
10秒前
10秒前
liu完成签到,获得积分10
10秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969322
求助须知:如何正确求助?哪些是违规求助? 3514152
关于积分的说明 11172188
捐赠科研通 3249407
什么是DOI,文献DOI怎么找? 1794832
邀请新用户注册赠送积分活动 875437
科研通“疑难数据库(出版商)”最低求助积分说明 804781